|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date † | January 20, 2009 | ||||||||
| Last Updated Date | January 21, 2009 | ||||||||
| Start Date † | January 2009 | ||||||||
| Current Primary Outcome Measures † |
Knowledge of melanoma detection. [ Time Frame: 1 month ] [ Designated as safety issue: No ] | ||||||||
| Original Primary Outcome Measures † | Same as current | ||||||||
| Change History | Complete list of historical versions of study NCT00826995 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures † |
Subjects' comprehension and attitude towards video-based and written education materials. [ Time Frame: 1 month ] [ Designated as safety issue: No ] | ||||||||
| Original Secondary Outcome Measures † | Same as current | ||||||||
| Descriptive Information | |||||||||
| Brief Title † | Comparison of Video-Based Versus Written Patient Education on Melanoma | ||||||||
| Official Title † | Comparison of Video-Based Versus Written Patient Education on Melanoma | ||||||||
| Brief Summary | The purpose of this study is to compare the effect of video-based patient education with written instruction on subjects' understanding of melanoma. |
||||||||
| Detailed Description | We plan to conduct a randomized, controlled trial comparing the effect of video-based patient education with written instruction on subjects' understanding of melanoma. Subjects randomized to the video-based education arm will be instructed to watch a video on the definition of melanoma, risk factors associated with the development of melanoma, and signs that should prompt an evaluation for melanoma. Subjects randomized to the written education arm will receive written information on the definition of melanoma, risk factors associated with the development of melanoma, and signs that should prompt an evaluation for melanoma. The contents of the video and the written educational materials will be comparable. At the end of the study period 1 month later, subjects will be interviewed via telephone regarding their understanding of melanoma. Subjects will also be interviewed regarding their comprehension and attitude towards video-based and written education materials. |
||||||||
| Study Phase | |||||||||
| Study Type † | Interventional | ||||||||
| Study Design † | Other, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment | ||||||||
| Condition † |
|
||||||||
| Intervention † | Other: Patient Educational Materials | ||||||||
| Study Arms / Comparison Groups |
|
||||||||
| Publications * | |||||||||
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status † | Recruiting | ||||||||
| Estimated Enrollment † | 70 | ||||||||
| Estimated Completion Date | December 2009 | ||||||||
| Estimated Primary Completion Date | June 2009 (final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||||||
| Gender | Both | ||||||||
| Ages | 18 Years and older | ||||||||
| Accepts Healthy Volunteers | Yes | ||||||||
| Contacts †† |
|
||||||||
| Location Countries † | United States | ||||||||
| Expanded Access Status | |||||||||
| Administrative Information | |||||||||
| NCT ID † | NCT00826995 | ||||||||
| Responsible Party | April W. Armstrong, MD, University of California Davis Health System | ||||||||
| Secondary IDs †† | |||||||||
| Study Sponsor † | University of California, Davis | ||||||||
| Collaborators †† | |||||||||
| Investigators † |
|
||||||||
| Information Provided By | University of California, Davis | ||||||||
| Verification Date | January 2009 | ||||||||
|
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |
|||||||||
